Replies to post #259940 on Avid Bioservices Inc (CDMO)

[hayward]

CloakedProctector

In our case (PPHM) the poison pill IMO works against us

1. We have a board that can NEVER be voted out
2. The board salary is the only thing that is astronomical
3 With a failed trial no employee decrease
4. No on held accountable for the stopped trial

5 AND NUMBER ONE ON MY LIST NOT A WORD FROM THE COMPANY AS TO WHAT THEY PLAN TO DO ABOUT IT !!!

Like Johnson getting to the bottom of the CMO fiasco. We are paying a corporate council more then we received in compensation for that

Michael

[InternetForumUser]

Hostile take-overs and Peregrine Pharmaceuticals? Are you really combining those two things? Management has been selling the company for pennies for the past decade.

Going to be close to 300 Million Outstanding Shares in 2016. In 2012 prior to the P2 Debacle, there was like 50+ Million Shares.

The only hostility that I have seen so far is Peregrine Managements Hostility towards Shareholders and increasing their investment. Call the Poison Pill for what it is.. It is a mechanism for Management to get what they want. The company has been making sure that Management and BOD are "well" insulated for the future.

Incorporating in Delaware
BOD Vote
Poison Pill
BOD Makeup (Good Ole Boy Network)
Option Issuance
No Open Market Purchases
Never Accepting ANYTHING on the PROXY
Not Allowing Shareholders to ask any questions during CC

The list goes on an on..

I am one who believes you indirectly work with or for Peregrine.

[thealias2002]

CP,

It's 100% a fact that any true long who has invested in PPHM during the last ten years has lost money here. There is no way for that not to happen and that is most certainly not an opinion. Please prove me wrong if you can.

Also, from: http://www.investopedia.com/ask/answers/042015/why-shareholder-rights-plan-called-poison-pill.asp

"Disadvantages of Shareholder Rights Plan
There are three major potential disadvantages to poison pills. The first is that stock values become diluted, so shareholders often have to purchase new shares just to keep even. The second is that institutional investors are discouraged from buying into corporations that have aggressive defenses. Lastly, ineffective managers can stay in place through poison pills; otherwise, outside venture capitalists might be able to buy the firm and improve its value with a better managing staff."

I'm not sure how you can stand by your assertions here, either. The last sentence is EXACTLY what I said myself.